Roughly one in 15 children receiving cancer treatment in low- and middle-income countries, or LMICs, die from treatment-related complications, new research published in The Lancet Oncology said.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.